<DOC>
	<DOCNO>NCT03028636</DOCNO>
	<brief_summary>A prospective , open label post market registry collect Patient Reported Outcomes online data capture registry , maintain Pelvalon , woman fecal incontinence exit LIBERATE study ( NCT02428595 ) continue use Eclipse System bowel control .</brief_summary>
	<brief_title>LIBERATE - PRO : Eclipseâ„¢ System Registry</brief_title>
	<detailed_description>All LIBERATE ( NCT02428595 ) study participant complete 12 month visit invite participate LIBERATE-PRO post market registry effort obtain additional long term quality life economic data . Subjects send email link survey ( ) mail printed survey depend choose survey delivery option complete 3 , 6 , 9 , 12 months.Baseline define baseline value LIBERATE study , prior insertion Eclipse System . The St. Mark 's ( Vaizey ) Incontinence Severity Score use assess severity accidental bowel leakage 3 , 6 , 9 , 12 month comparison prior join LIBERATE study . The score base 7 question measure severity fecal incontinence ( FI ) symptom , show correlate improvement frequency FI episodes subject ' perception relief . The composite score calculate question reflect severity FI range 0 ( complete continence ) 24 ( complete incontinence ) . The change baseline score calculate time point . The average change baseline score , compute mean change baseline across complete assessment , calculate . The Patient Global Impression Improvement ( PGI-I ) validate global index use rate response condition therapy scale 1 ( Very much good ) 7 ( Very much bad ) . The PGI-I use assess improvement accidental bowel leakage 3 , 6 , 9 , 12 month comparison prior join LIBERATE study . The average PGI-I score , compute mean score across complete assessment , calculate . The FIQOL ( Fecal Incontinence Quality Life Questionnaire complete 12 month . The Fecal Incontinence Quality Life ( FIQOL ) scale 41-item , validated questionnaire complete subject . FIQOL 4 subscales : lifestyle , coping/behavior , depression/self-perception embarrassment . Each subscale score range 1 5 , 1 indicate low functional status quality life . FIQOL score use ass change quality life subscales comparison score prior join LIBERATE study.The change baseline 4 subscale score ( lifestyle , coping/behavior , depression/self-perception , embarrassment ) calculate . The Eclipse Experience feedback ( question relate perception device comfort , satisfaction usage feature , impact daily activity ) collect 3 , 6 , 9 , 12 month . All outcome summarize descriptively time point .</detailed_description>
	<mesh_term>Fecal Incontinence</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<criteria>Subject complete 12month visit LIBERATE study ( NCT02428595 ) Subject elect continue use Eclipse System outside LIBERATE study Subject provide electronic informed consent HIPAA authorization There specific exclusion data collection registry commercially approve product</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>fecal incontinence</keyword>
	<keyword>bowel control</keyword>
	<keyword>accidental bowel leakage</keyword>
	<keyword>medical device</keyword>
	<keyword>woman 's health</keyword>
	<keyword>vaginal insert</keyword>
	<keyword>pessary</keyword>
	<keyword>incontinence</keyword>
	<keyword>bowel continence</keyword>
	<keyword>pump</keyword>
</DOC>